Vitamin D status and cancer: new insights

Curr Opin Clin Nutr Metab Care. 2007 Jan;10(1):6-11. doi: 10.1097/MCO.0b013e328011aa60.

Abstract

Purpose of review: The aim of this article is to describe recent developments in human studies of the role of vitamin D in the etiology and treatment of cancer.

Recent findings: Epidemiologic studies over the past year lend additional support for important roles for vitamin D in the natural history of several cancers. Studies showing risk reduction by vitamin D in prostate, colon and breast cancers were joined by new analyses of endometrial, skin, and pancreatic cancers. Interest in vitamin D has extended to examinations of its influence on premalignant conditions such as adenomatous polyps and breast density. Studies of vitamin D and cancer survival have featured prominently in the recent literature. Sun exposure and indicators of high vitamin D status were found to be associated with improved survival for cutaneous melanoma, Hodgkin's lymphoma, and cancers of the lung, breast, prostate and colon. Therapeutic trials of vitamin D are especially prominent in the treatment of prostate cancer.

Summary: Studies over the past year indicate potentially important roles for vitamin D in cancer prevention, survival and treatment.

Publication types

  • Review

MeSH terms

  • Anticarcinogenic Agents
  • Humans
  • Neoplasms / epidemiology*
  • Neoplasms / prevention & control*
  • Nutritional Status*
  • Precancerous Conditions
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Survival Analysis
  • Vitamin D / physiology*
  • Vitamins / physiology*

Substances

  • Anticarcinogenic Agents
  • Vitamins
  • Vitamin D